Has John Lavo, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,923 in general payments to John Lavo, MD across 131 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Lavo, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Lavo, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Lavo, MD

Otolaryngology · Bossier City, LANPI 1851787071

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.0% of the total across 131 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 47.8% of the total. 2025 is the largest year on record at $1,296, more than ten times the $19 reported in 2019.

$3,923in general payments, 2019–2025

Across 131 payments — averaging $29.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Inspire Medical Systems, Inc.$2K
Sanofi$479
Johnson & Johnson$397
Medtronic$269
GSK$171
ARS Pharmaceuticals Operations, Inc.$150
plus $583 from 13 others

What the payments were for

Food & beverage$3,80597%
Education$1183%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Inspire Medical Systems, Inc.	65	$1,874
Sanofi	24	$479
Johnson & Johnson(2 entities)	4	$397
Medtronic	6	$269
GSK	7	$171
ARS Pharmaceuticals Operations, Inc.	2	$150
Acclarent, Inc	4	$129
Sanofi-aventis U.S. LLC	2	$99
Stryker	2	$82
Regeneron Healthcare Solutions, Inc.	3	$50
Aerin Medical Inc.	2	$46
Intersect ENT, Inc.	2	$39
AstraZeneca	2	$35
Triad Life Sciences Inc.	1	$30
AMAG Pharmaceuticals, Inc.	1	$19
Itamar Medical Inc	1	$19
Hologic Sales And Service, LLC	1	$14
Bolder Surgical LLC	1	$12
Olympus America Inc.	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Inspire$450
TRUMATCH$383
Inspire Upper Airway Stimulation System$262
PROPEL$175
NEFFY$125
MATRIXMIDFACE$123
MATRIXMANDIBLE$123

How this compares

$3,923 in reported general payments places this provider in the 75th percentile of 218 otolaryngology providers in Louisiana.

See all otolaryngology providers in Louisiana →

Medicare billing

Part B allowed, 2024

$112,019

Medicare patients

329

Services billed

1,467

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Azelastine Hcl	71	$1,407
Ipratropium Bromide	56	$1,399
Fluticasone Propionate	104	$1,342
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth	13	$1,243
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	35	$437
Famotidine	37	$158
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	12	$39

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Bossier City

Glen WatkinsBossier City$7K
Kevin MooreBossier City$4K
Donald GonzalesNew Orleans$351K
Kevin McLaughlinCovington$186K
Adil FatakiaMarrero$148K
Edward McCoulNew Orleans$92K
Michael YimShreveport$77K
Maura CosettiShreveport$64K
Lizabeth ClarkeNew Iberia$40K
Henry BarhamBaton Rouge$32K

See the full list for Louisiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →